Olympus Corp banner

Olympus Corp
F:OLY

Watchlist Manager
Olympus Corp Logo
Olympus Corp
F:OLY
Watchlist
Price: 7.95 EUR 0.63%
Market Cap: €8.9B

P/OCF

13.7
Current
45%
Cheaper
vs 3-y average of 25.1

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
13.7
=
Market Cap
€1.6T
/
Operating Cash Flow
¥123.5B

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
13.7
=
Market Cap
€1.6T
/
Operating Cash Flow
¥123.5B

Valuation Scenarios

Olympus Corp is trading below its 3-year average

If P/OCF returns to its 3-Year Average (25.1), the stock would be worth €14.55 (83% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-16%
Maximum Upside
+83%
Average Upside
37%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 13.7 €7.95
0%
3-Year Average 25.1 €14.55
+83%
5-Year Average 23 €13.33
+68%
Industry Average 15.3 €8.89
+12%
Country Average 11.5 €6.64
-16%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
JP
Olympus Corp
F:OLY
1.7T EUR 13.7 20
US
Intuitive Surgical Inc
NASDAQ:ISRG
171.7B USD 56.7 60.1
US
Abbott Laboratories
NYSE:ABT
159.2B USD 16.6 25.4
US
Stryker Corp
NYSE:SYK
126B USD 25 38.8
IE
Medtronic PLC
NYSE:MDT
106.8B USD 14.7 23.2
US
Boston Scientific Corp
NYSE:BSX
96.2B USD 21.2 33.2
DE
Siemens Healthineers AG
XETRA:SHL
41.6B EUR 13.5 19.4
US
Edwards Lifesciences Corp
NYSE:EW
47.3B USD 29.7 44.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
46.1B USD 39 43.5
US
Becton Dickinson and Co
NYSE:BDX
44.3B USD 13.1 25.2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
32.5B USD 16.4 15.6

Market Distribution

Lower than 100% of companies in Japan
Percentile
0th
Based on 4 634 companies
0th percentile
0.1
Low
0.1 — 8
Typical Range
8 — 16
High
16 —
Distribution Statistics
Japan
Min 0.1
30th Percentile 8
Median 11.5
70th Percentile 16
Max 277 515 329.3

Olympus Corp
Glance View

Market Cap
8.9B EUR
Industry
Health Care

Olympus Corporation, originating from the heart of Japan in 1919, has evolved into a global powerhouse, particularly revered for its contributions to the field of optics and imaging. Initially carving its reputation through crafting precision microscope lenses, Olympus seamlessly expanded its capabilities into the realms of endoscopy and digital imaging. This strategic pivot not only defined its legacy but firmly anchored its presence in the medical world, where it became a leader in endoscopic technology. The company adeptly leveraged its expertise to revolutionize medical diagnostics and treatment, helping medical professionals see and diagnose better—enhancing both physician dexterity and patient outcomes. Revenue for Olympus is predominantly driven by its Medical Business sector, which constitutes a significant portion of its overall profits, underscoring its transformation from a diversified manufacturer to a specialized player in healthcare technology. They are deeply committed to R&D, funneling substantial resources to innovate and bolster their portfolio in medical devices, particularly in fields like therapeutic interventions. While imaging products for consumers have historically been a notable segment, the shift toward medical technology aligns with broader market demands and ensures sustainable growth. This focus demonstrates Olympus's intent to maximize its competitive advantages, allowing it to remain at the forefront of its niche industries and effectively respond to global healthcare challenges.

OLY Intrinsic Value
11.53 EUR
Undervaluation 31%
Intrinsic Value
Price €7.95
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett